Clinical trial Recruiting at 1 site Interventional Ages 15 to 24

Evaluating sleep quality in young cancer survivors

Official title: Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

Run by Centre Hospitalier Universitaire de Nice · NCT06904495 · Data updated 2026-11-12

This study is trying to see how well young cancer survivors aged 15 to 24 sleep after their treatment and what factors might affect their sleep quality.

Quick facts

Study typeInterventional
Ages15 Years to 24 Years
SexAll
Enrollment400 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Nice)
StatusRecruiting
StartedApril 15, 2025
Main results expectedMay 5, 2026
Study endsMay 5, 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT06904495 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are cancer survivors aged 15 to 24 who completed their treatment at least three months ago and are being followed at a designated cancer center.

Probably not a fit

Patients with major cognitive impairments or those unable to use computer tools may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the sleep quality of cancer survivors aged 15 to 24 years who were treated for cancer. It aims to understand the long-term impacts of cancer treatments on sleep disorders in this age group, which is often overlooked. Participants will complete a questionnaire to evaluate their sleep quality and related factors. The study focuses on those who have completed their intensive cancer treatment at least three months prior and are being followed at a specialized cancer center.

Why it matters

Potential benefit: If successful, this study could lead to improved management and treatment of sleep disorders in young cancer survivors.

How similar studies have gone: While there is limited research specifically on sleep quality in this demographic, studies on sleep disorders in cancer survivors have shown varying degrees of success in addressing related issues.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient treated for a cancer
* Patient aged between 15 and 24 years old at the time of the diagnosis
* Patients whom intensive treatment ended at least 3 months ago
* Patient followed in a PACAAURA cancerology center
* Life expectancy ≥ 6 months
* Karnosky index \> 60%
* Patient who agrees to participate in the program and benefits from social security
* Patient able to understand, speak and read French.
* No major cognitive impairment (assessed by the patient's referees)
* No sensory disability

Exclusion Criteria:

* Patient unable to use informatic tools
* Known superior cognitive function disorders
* Progressive psychiatric pathology
* Drug user or alcohol abuse

Where it's running

  • CHU de Nice
    Nice, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.